A survey of 400 Ohioans, most of whom are medical marijuana users, found widespread dissatisfaction with the legal MED program in the potentially major cannabis market. (Read the survey here.)
Conducted by The Ohio State University’s Drug Enforcement and Policy Center, the second annual survey found plenty of complaints about the state’s cannabis program.
The survey found 61.6% of Ohioans are somewhat or extremely dissatisfied with legal MED in Ohio. The number represents an improvement from 2019 when 67% were dissatisfied. By contrast, 27.8% of respondents reported that they were somewhat or extremely satisfied with the program, up from 16.7% last year.
A large majority of respondents said they preferred to purchase medical cannabis at licensed dispensaries but found substantial obstacles to doing so. The barriers include the price of legal product and the difficulty of the registration process and obtaining a doctor’s recommendation.
The cost of legal product remains a significant source of dissatisfaction. Pot costs an average of $18.18 per gram at Ohio dispensaries compared to $8.42 on the illegal market and $9.38 at Michigan dispensaries.
Of those patients who have a qualifying condition, the largest number reported not using MED because it’s too expensive and because they are worried about losing their job. They’re also worried about other legal consequences stemming from the federal illegality of cannabis.
After passing legislatively, Ohio’s MED program took effect in September 2016, making the Buckeye State the 25th to legalize some form of MED. It remains a relatively small program, grossing $151.9M in sales since January 2019. For comparison, Oklahoma, with a far smaller population, saw $300M in MED sales in the first five months of this year.
WeedWeek is the essential news source for people who make money in the cannabis industry. Our coverage focuses on the business, political, regulatory and legal news professionals need.
We publish throughout the week and send newsletters on Wednesday and Saturday.
Starting soon, most of our premium content will only be available to paid subscribers. For now, it’s still free. Over the next few weeks, we’ll do our best to prove to you that our reporting and work will be well worth your subscription.
Since 2015, WeedWeek has been the best way to keep up with the cannabis world. WeedWeek’s audience includes many of the most influential figures in cannabis because we are editorially independent: Advertisers have no influence on our editorial content.
Follow us on Google News, and be the first to see new WeedWeek stories.
Our success is depends on the value you get from our work, and we want to hear your input. Email firstname.lastname@example.org with the issues you’re facing, your thoughts on our coverage or whatever else is on your mind. To advertise contact email@example.com.